Medical Care with telemedicine of ambulant patients with diabetes mellitus type 1 and 2

Not Applicable

• Conditions: E10; E11; Type 1 diabetes mellitus; Type 2 diabetes mellitus

• Registration Number: DRKS00003140
• Lead Sponsor: niversitätsklinikum Jena

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-06-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 22

Inclusion Criteria

1. diabetes type 1 or type 2, access to the internet and telephone, 2. positive informed consent, 3. support in the study center at controls after study 4. duration of diabetes at least one year, 5. participation of a treatment and teaching programme,6. not achieve the treatment goal above two quarters: patients with diabetes type 1: HbA1c >=8% and /or >3 not severe hypoglycemia per week and/or 1 or more nocturnal hypoglycemia; patients with diabetes type 2: HbA1c >=8% and / or >1 not severe hypoglycemia per week

Exclusion Criteria

1. not give their informed consent, 2. patients with indication for hospital treatment, 3. patients who are not able to fulfill the technical requirements, 4. patients with depression, 5. patients with severe concomitant diseases, 6. pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c measured at baseline, 3 and 6 months after Randomisation

Secondary Outcome Measures

Name	Time	Method
incidence of hypoglycemia will be enquired at baseline, 3 and 6 months after Randomisation, treatment satisfaction will be detect with the DTSQ questionaire at baseline and after 6 months, diabetes dependent quality of life will be detect with the ADDQoL questionaire at baseline and after 6 months, medical costs will be calculated after 6 months